Xtandi, the brand name for enzalutamide, is a prescription medication used primarily for the treatment of prostate cancer. It is designed for patients with metastatic castration-resistant prostate cancer (mCRPC) and has shown significant efficacy in extending overall survival and delaying disease progression.
Enzalutamide works by blocking the effects of androgens (male hormones) that can promote the growth of prostate cancer cells. By interfering with androgen receptor signaling, Xtandi helps to inhibit cancer cell proliferation and induces apoptosis (programmed cell death).
The typical dosage of Xtandi is 160 mg taken once daily, with or without food. It is crucial to follow your healthcare provider's instructions regarding dosage and administration.
Common side effects may include fatigue, hot flashes, hypertension, and gastrointestinal disturbances. It is important to report any severe or persistent side effects to your healthcare provider.
Before starting Xtandi, inform your healthcare provider about any pre-existing conditions, allergies, or other medications you may be taking. Regular monitoring of blood pressure and other health parameters is recommended during treatment.
Always consult your healthcare provider for personalized medical advice and to ensure that Xtandi is the right option for your treatment plan. This medication is only available with a prescription and should be used under medical supervision.
Prescription Required 
India
